| Useful Advices |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Business > Top7 or 10 Tips > 10 Steps for Simplifying Business Plan Financial Statements |
|
Useful Advices - 10 Steps for Simplifying Business Plan Financial Statements
For most business owners and entrepreneurs, preparing, and communicating the financial statement section of a business plan is like trying to give driving directions to someone who doesn't speak the same language. "Numbers" is the language most investors speak. But, it is also the language that many business owner According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product s and entrepreneurs don't speak or understand. So how do you bridge this gap? 1) Understand there is a difference between "crunching" or preparing the financial statements and presenting them. Preparing business plan financial statements often requires expert knowledge of double-entry accounting, taxes, me ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in rger and acquisition accounting, and finance. Skills most business owners or entrepreneurs don't have, except for perhaps the most seasoned or those with accounting backgrounds. Presenting the numbers, however, only requires that you understand how what you plan to do translates into cash; and, what the potential fi lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. nancial risks for the business are, and how you'll minimize them. If you cannot demonstrate that you understand these, then why would an investor ever give you money? 2) Get help early on. Okay so you don't have any money to hire a CPA or an accountant, and they just won't do it for nothing. Reach out to yo here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe ur local college. Find the head of the accounting department or an accounting professor. Then, see how your project might be used to help the class learn about accounting, starting a business, or building financial models. The point is; you need someone who understands how to build projected financial statements bas d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro ed on your specific plans for the business. It is also important to find someone who can help you understand your financial statements. 3) Know the kind of investor you are seeking. This is the same as a writer taking the time to know the audience before writing a book. For example, a banker puts more weig ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc ht on the business' liquidity, collateral, and ability to convert assets into cash quickly if the business runs into trouble and a loan is called. The emphasis on these financial measures is different for a venture capitalist whose interest is more on how quickly your business can grow, the potential future cash flo easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi it can generate, and the potential for cashing out at an amount much higher than the initial investment. 4) Present only the numbers and measures most important to your type or types of investors in the body of your business plan. Save the more detailed financial statements for the appendix and due dilige nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically nce stage. Of course you need detailed financial statements and projections to support your business plan, but don't think you need to share them with potential investors upfront. Investors are more interested in seeing if a few key numbers and financial measures make sense and that they support your strategies befo and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ re they waste time digging through your supporting data. If they are interested in moving forward with you, believe me, they will dig into your financial statements. 5) Use graphs and tables wisely to present financial information. Graphs are great for presenting trends and comparisons. Keep them simple and ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi uncluttered. Be sure headings, labels, axis tabs, and so on are clear and legible. Nothing is better than a great graph or table to convey a message clearly and quickly. But remember, a bad graph or table can create much damage and confusion too. 6) Check you numbers. Like typos, a wrong number can shatter ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a your credibility instantly. It can cause your potential investors to lose confidence in your ability, or to question your understanding of the business. Be sure the numbers in your plan agree to the correct model or version of your financial plan. Verify the numbers in your business plan agree to all supporting doc dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod uments. 7) Always include a statement of the sources and uses of cash. If you have teenagers, I'm sure you always ask them where they're going to spend the money you're about to give them, before you hand the money over to them. The Statement of Sources and Uses does the same for investors. It tells potent cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin ial investors how you plan to use their money. The statement accounts for all the money coming into the deal, whether it is bank debt, seller notes, personal cash, cash proceeds from the sale of stock, and so on. It then explains how you intend to use this money, whether it is to buy an existing business, buy certai tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen assets, payoff existing debt, or payoff certain start-up liabilities, fees, and expenses. 8) Include all three fundamental financial statements: income statement, balance sheet and cash flow. Don't just provide potential investors with an income statement, it doesn't give them the complete story. Also, be t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel sure that all financial statements conform to Generally Accepted Accounting Principals or GAAP. Include at least three years of actual historical financial information, if available, and five years of projected financial statements. Although no one expects you to be able to predict the future with absolute certainty ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust , projections do provide insight into your thought process, assumptions, and understanding of the business and its markets. 9) Maintain a good financial model capable of running sensitivity analyses to show how your projected results will change as your assumptions change. This allows you and your investor y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products s to identify which assumptions are most critical to your future performance. Each critical assumption needs evidence to support it. Also, include in your model benchmark comparisons to other companies in your industry. Compare things like revenues per employee, gross margin per employee, gross margin as a percentag . As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de e of revenues, and various expense and balance sheet ratios. 10) Use footnotes and descriptions to explain how key numbers were derived or the specific assumptions behind them. As much as possible, keep these short and to the point. Don't get carried away footnoting every number. Footnote only key numbers elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip or unusual items. At the end of the day, more business deals are not consummated because investors don't feel like they can trust the numbers for one reason or another. Spend the time, effort and money to communicate your financial statements clearly and convincingly. It can be the key to making your deal a reality tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:The Beckham's Brand Developement - Where next? Trade Show Promotions That Are Memorable Webconference Applications For Sales
|